Kalif Eliyahu Sharon

Insider profile

Kalif Eliyahu Sharon's trades of Teva Pharmaceutical Industries Limited's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-16 2026-06-11
PlS Planned sale
2,565 -39.7%
479.21
US$4,385,930 		2,565 -39.7% 479.21 US$4,385,930
2026-06-11 2026-06-11
PrS Proposed sale
38,382
176.54
US$186,512 		38,382 176.54 US$186,512
2026-06-11 2026-06-11
PrS Proposed sale
56,663
268.92
US$1,009,169 		56,663 268.92 US$1,009,169
2026-05-18 2026-05-14
PlS Planned sale
153,251 -47.1%
35.61
US$5,457,375 		153,251 -47.1% 35.61 US$5,457,375
2026-05-14 2026-05-14
PrS Proposed sale
153,251
35.61
US$5,457,369 		153,251 35.61 US$5,457,369
2026-03-02 2026-02-26
PlS Planned sale
345,810 -85.7%
33.64
US$11,634,708 		345,810 -85.7% 33.64 US$11,634,708
2026-02-26 2026-02-26
PrS Proposed sale
345,810
33.64
US$11,634,702 		345,810 33.64 US$11,634,702
2025-06-16 2025-06-12
PlS Planned sale
55,775 -12.1%
17.08
US$952,464 		55,775 -12.1% 17.08 US$952,464
2025-06-12 2025-06-12
PrS Proposed sale
55,775
17.08
US$952,466 		55,775 17.08 US$952,466
2025-03-04 2025-02-28
PlS Planned sale
55,750 -27.4%
16.21
US$903,462 		55,750 -27.4% 16.21 US$903,462
2025-02-28 2025-02-28
PrS Proposed sale
55,750
16.21
US$903,463 		55,750 16.21 US$903,463
2024-03-07 2024-03-06
PlS Planned sale
77,550 -27.6%
13.52
US$1,048,119 		77,550 -27.6% 13.52 US$1,048,119
2023-08-09 2023-08-07
S Sale
35,125 -26.2%
9.73
US$341,889 		35,125 -26.2% 9.73 US$341,889
2022-08-24 2022-08-22
PlS Planned sale
55,500 -85.5%
10.07
US$558,696 		55,500 -85.5% 10.07 US$558,696